Eubulus

Recent Finacing

Series A

Recent Raise

Undisclosed

Eubulus Biotherapeutics develops cell- and tissue-targeted protein-degradation therapeutics (PROTAC-style) via its TED platform and multifunctional linkers to improve permeability and ADME, and advances ferroptosis-inducing small molecules for oncology.